Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial

Katalin Boér, István L↭g, Éva Juhos, Tamás Pintér, János Szántó

Open source

DOI
10.1007/bf03033731
Published
2003-09
Container
Pathology & Oncology Research
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/bf03033731,
  title = {Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial},
  author = {Katalin Boér and István L↭g and Éva Juhos and Tamás Pintér and János Szántó},
  year = {2003},
  journal = {Pathology \& Oncology Research},
  doi = {10.1007/bf03033731},
  url = {https://doi.org/10.1007/bf03033731}
}

RIS

TY  - JOUR
TI  - Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial
AU  - Katalin Boér
AU  - István L↭g
AU  - Éva Juhos
AU  - Tamás Pintér
AU  - János Szántó
PY  - 2003
JO  - Pathology & Oncology Research
DO  - 10.1007/bf03033731
UR  - https://doi.org/10.1007/bf03033731
ER  - 

APA

Boér, K., L↭g, I., Juhos, É., Pintér, T., & Szántó, J. (2003). Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) — A Hungarian experience in the BCIRG 001 trial. Pathology & Oncology Research. https://doi.org/10.1007/bf03033731

Source records